phosphonoacetic acid has been researched along with hydroxyurea in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Roizman, B; Wolf, H | 1 |
| Iwasaka, T; Miyazono, J; Mori, R; Oda, H | 1 |
| Davidson, K; Forseth, B; Scott, J; Von Hoff, DD; Waddelow, T; Wahl, G | 1 |
| Colinas, RJ; Condit, RC; Paoletti, E | 1 |
| Gibson, W; Irmiere, A; Lee, JY | 1 |
| Bayliss, GJ; Wolf, H | 1 |
| Lamon, EW; Lidin, BI | 1 |
| Huang, A; Wright, JA | 1 |
| Coen, DM; Digard, P; Staknis, D; Wobbe, KK | 1 |
| Ahlgren, JD; Anderson, N; Kemeny, N; Lokich, JJ | 1 |
| Fan, H; Huang, A; Taylor, WR; Wright, JA | 1 |
| Beeche, M; Bodnar, AG; Chang, E; Chiu, CP; Frolkis, M; Jiang, XR; Jimenez, G; Kusler, B; Sage, M; Tlsty, TD; Wahl, GM | 1 |
| Agarwal, A; Agarwal, ML; Stacey, DW; Stark, GR; Taylor, WR | 1 |
| Fornace, AJ; Hollander, MC; Patterson, AD; Philburn, RT; Wyatt, MA | 1 |
1 review(s) available for phosphonoacetic acid and hydroxyurea
| Article | Year |
|---|---|
Recent advances in the treatment of advanced colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Colorectal Neoplasms; Drug Administration Schedule; Drug Interactions; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Hydroxyurea; Infusions, Intra-Arterial; Leucovorin; Methotrexate; Neoplasm Staging; Phosphonoacetic Acid; Prospective Studies; Randomized Controlled Trials as Topic | 1993 |
14 other study(ies) available for phosphonoacetic acid and hydroxyurea
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
The regulations of gamma (structural) polypeptide synthesis in herpes simplex virus types 1 and 2 infected cells.
Topics: DNA, Viral; Half-Life; Hydroxyurea; Peptide Biosynthesis; Phosphonoacetic Acid; RNA, Messenger; RNA, Viral; Simplexvirus; Viral Proteins | 1978 |
Effects of antimetabolites on the production of tubular structures in Vero cells infected with herpes simplex virus type 2.
Topics: Animals; Cell Line; Cell Nucleus; Cytochalasin B; Cytopathogenic Effect, Viral; Deoxyglucose; Dose-Response Relationship, Drug; Haplorhini; Hydroxyurea; Idoxuridine; Kidney; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus | 1979 |
Hydroxyurea accelerates loss of extrachromosomally amplified genes from tumor cells.
Topics: Aspartate Carbamoyltransferase; Aspartic Acid; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Carcinoma, Squamous Cell; Cell Division; Chromosome Deletion; Dihydroorotase; DNA Replication; Drug Resistance; Gene Amplification; Humans; Hydroxyurea; Methotrexate; Multienzyme Complexes; Phosphonoacetic Acid; Plasmids; Tumor Cells, Cultured; Vinblastine | 1991 |
Extrachromosomal recombination in vaccinia-infected cells requires a functional DNA polymerase participating at a level other than DNA replication.
Topics: Animals; beta-Galactosidase; Cells, Cultured; Cytarabine; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Genetic Markers; Hot Temperature; Hydroxyurea; Lac Operon; Mutation; Phosphonoacetic Acid; Plasmids; Recombination, Genetic; Sequence Homology, Nucleic Acid; Vaccinia virus; Virus Replication | 1990 |
Primate cytomegalovirus assembly: evidence that DNA packaging occurs subsequent to B capsid assembly.
Topics: Capsid; Cells, Cultured; Centrifugation, Density Gradient; Cytomegalovirus; DNA, Viral; Electrophoresis, Polyacrylamide Gel; Fibroblasts; Foscarnet; Humans; Hydroxyurea; Microscopy, Electron; Phosphonoacetic Acid; Virion | 1988 |
The regulated expression of Epstein-Barr virus. III. Proteins specified by EBV during the lytic cycle.
Topics: Antigens, Viral; Azetidines; Canavanine; Cells, Cultured; Cycloheximide; DNA Replication; DNA, Viral; Gene Expression Regulation; Herpesvirus 4, Human; Humans; Hydroxyurea; Phosphonoacetic Acid; Precipitin Tests; Time Factors; Viral Proteins | 1981 |
Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.
Topics: Antigens, Viral; Burkitt Lymphoma; Cell Line; Cytarabine; DNA, Viral; Gene Expression Regulation; Genes, Viral; Herpesvirus 4, Human; Humans; Hydroxyurea; Phosphonoacetic Acid; Virus Cultivation | 1983 |
Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification.
Topics: Animals; Antineoplastic Agents; Aspartate Carbamoyltransferase; Aspartic Acid; Blotting, Southern; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cell Line; Dihydroorotase; DNA; Drug Resistance; Fibroblast Growth Factor 2; Fibroblast Growth Factor 4; Fibroblast Growth Factors; Fibroblasts; Gene Amplification; Hydroxyurea; Methotrexate; Mice; Multienzyme Complexes; Phosphonoacetic Acid; Proto-Oncogene Proteins; Ribonucleotide Reductases; Suramin; Tetrahydrofolate Dehydrogenase; Transfection | 1994 |
Unusual regulation of expression of the herpes simplex virus DNA polymerase gene.
Topics: Animals; Aphidicolin; DNA Replication; DNA-Directed DNA Polymerase; Ganciclovir; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Viral; Genes, pol; Hydroxyurea; Kinetics; Phosphonoacetic Acid; Protein Biosynthesis; RNA, Messenger; RNA, Viral; Simplexvirus; Thymidine Kinase; Transcription, Genetic; Vero Cells | 1993 |
Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Antisense Elements (Genetics); Aspartic Acid; Drug Resistance, Neoplasm; Gene Amplification; Gene Expression Regulation, Enzymologic; Genes, p53; Genetic Vectors; Hydroxyurea; L Cells; Methotrexate; Mice; Phosphonoacetic Acid; Retroviridae; Ribonucleotide Reductases; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 1997 |
Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype.
Topics: Aspartic Acid; Cell Line; Cell Line, Transformed; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase Inhibitor p16; DNA-Binding Proteins; Enzyme Inhibitors; Humans; Hydroxyurea; Nucleic Acid Synthesis Inhibitors; Phenotype; Phosphonoacetic Acid; Phosphorylation; Protein Biosynthesis; Proteins; Retinoblastoma Protein; RNA; Telomerase; Tumor Cells, Cultured | 1999 |
p53 inhibits entry into mitosis when DNA synthesis is blocked.
Topics: Animals; Aspartic Acid; Cell Line, Transformed; Chromatin; DNA Replication; Histones; Humans; Hydroxyurea; Mice; Mitosis; Phosphonoacetic Acid; Phosphorylation; Spindle Apparatus; Tumor Suppressor Protein p53 | 1999 |
Genomic instability in Gadd45a-/- cells is coupled with S-phase checkpoint defects.
Topics: Aneuploidy; Animals; Aspartic Acid; Cell Cycle Proteins; Cell Line; Centrosome; Chromosome Segregation; Cyclin-Dependent Kinase Inhibitor p21; DNA; DNA Replication; G1 Phase; Gene Amplification; Gene Deletion; Gene Expression Regulation; Genes, cdc; Genes, p53; Genomic Instability; Hydroxyurea; Mice; Nuclear Proteins; Phosphonoacetic Acid; S Phase | 2005 |